Kinesiophobia, Pain, Functional Status and Self-Efficacy in Patients With Knee Osteoarthritis

September 3, 2021 updated by: Nurhayat KORKMAZ, Hacettepe University

Relationship Between Kinesiophobia, Pain, Functional Status and Self-Efficacy in Patients With Knee Osteoarthrıtıs

Objective: The aim of this study is to examine the relationship between kinesiophobia, pain, functional status and self efficacy in patients with knee osteoarthritis.

Study Overview

Status

Completed

Conditions

Detailed Description

Material and Methods: The study was performed on 72 individuals diagnosed with Stage 2 and Stage 3 knee osteoarthritis according to the Kellgren Lawrence classification. The Tampa Scale for Kinesiophobia (TSK) was used to evaluate kinesiophobia, and the Visual Analogue Scale (VAS) was used to assess pain. The Western Ontario and McMaster Universities Arthritis Index (WOMAC) was used to asses the functional status. Self efficacy was assessed using the Arthritis Self Efficacy Scale (ASES).

Study Type

Observational

Enrollment (Actual)

72

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Hacettepe University Faculty of Physical Therapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

community sample

Description

Inclusion Criteria:

  • Being between the ages of 40-85 and diagnosed with stage 2-3 bilateral knee osteoarthritis according to Kellgren Lawrence classification.

Exclusion Criteria:

  • With a history of lower extremity surgery and a major trauma, orthopedic knee injuries such as tendinopathy, bursitis, ligament and meniscus injuries, a neurological or cardiopulmonary disease that may affect the evaluations, and any other joint in the lower limb that may cause reflected pain in the knee, individuals who had inflammatory rheumatic disease such as gout, rheumatoid arthritis, have participated in physical therapy and rehabilitation program in the last 6 months and who have been given knee injections

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stage 2 Knee osteoarthritis
The Visual Analogue Scale (VAS) was used to determine the severity of the pain. Tampa Scale for Kinesiophobia (TSK) was used to evaluate kinesiophobia. The functional state was evaluated using The Western Ontario and McMaster Universities Arthritis Index (WOMAC). The Arthritis Self Efficacy Scale was used to determine self efficacy perception.
The Kellgren Lawrence classification was used in the radiological evaluation. It is a classification method used in the staging of knee osteoarthritis. Five stages were defined according to the anteroposterior X-ray.(Stage 0-5)
Stage 3 Knee osteoarthritis
The Visual Analogue Scale (VAS) was used to determine the severity of the pain. Tampa Scale for Kinesiophobia (TSK) was used to evaluate kinesiophobia. The functional state was evaluated using The Western Ontario and McMaster Universities Arthritis Index (WOMAC). The Arthritis Self Efficacy Scale was used to determine self efficacy perception.
The Kellgren Lawrence classification was used in the radiological evaluation. It is a classification method used in the staging of knee osteoarthritis. Five stages were defined according to the anteroposterior X-ray.(Stage 0-5)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: After the participants were examined, evaluations were made before starting the physical therapy program.
Pain assessment, between 0-10 points. Low score low pain
After the participants were examined, evaluations were made before starting the physical therapy program.
Tampa Scale for Kinesiophobia
Time Frame: After the participants were examined, evaluations were made before starting the physical therapy program.
Kinesiophobia assessment, between 17-68 points. Low score low kinesiophobia.
After the participants were examined, evaluations were made before starting the physical therapy program.
The Western Ontario and McMaster Universities Arthritis Index
Time Frame: After the participants were examined, evaluations were made before starting the physical therapy program.
Functional state assessment, between 0-96 points. Low score good functional status.
After the participants were examined, evaluations were made before starting the physical therapy program.
Arthritis Self Efficacy Scale
Time Frame: After the participants were examined, evaluations were made before starting the physical therapy program.
Self Efficacy assessment, between 20-100 points. Low score low self-efficacy.
After the participants were examined, evaluations were made before starting the physical therapy program.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hacettepe Üniversity, Intitue, Hacettepe University Health Sciences Institute
  • Principal Investigator: Nurhayat Korkmaz, PhDstudent, Hacettepe University Health Sciences Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 20, 2018

Primary Completion (ACTUAL)

April 2, 2018

Study Completion (ACTUAL)

February 20, 2019

Study Registration Dates

First Submitted

August 27, 2021

First Submitted That Met QC Criteria

September 3, 2021

First Posted (ACTUAL)

September 5, 2021

Study Record Updates

Last Update Posted (ACTUAL)

September 5, 2021

Last Update Submitted That Met QC Criteria

September 3, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Kellgren Lawrence classification

3
Subscribe